Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers

被引:5
|
作者
Jesus Lallana, Maria [1 ]
Feja, Cristina [2 ]
Aguilar-Palacio, Isabel [2 ]
Malo, Sara [2 ]
Jose Rabanaque, Maria [2 ]
机构
[1] Pharm Serv Primary Hlth Care, Aragones Hlth Serv, Zaragoza 50009, Spain
[2] Univ Zaragoza, Deparment Microbiol Prevent Med & Publ Hlth, E-50009 Zaragoza, Spain
关键词
non-steroidal anti-inflammatory drugs; gastrointestinal protection; pharmacoepidemiology; GASTROINTESTINAL COMPLICATIONS; NSAIDS; RISK; METAANALYSIS; NATIONWIDE; DATABASE; AGENTS; TRENDS; CARE;
D O I
10.3390/ijerph15091836
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: This study describes the prevalence of non-steroidal anti-inflammatory drug (NSAID) use, and analyses prescribing patterns of NSAIDs and associated gastroprotection. Methods: The study population consisted of 5650 workers at the General Motors automobile assembly plant in Zaragoza, Spain. NSAID prescription data for 2014 were obtained from the prescription database of Aragon (Spain). NSAID consumption was determined based on the number of defined daily doses purchased per year. Heavy NSAIDs users were identified using Lorenz curves. Results: NSAID use in the cohort was high (40.7% of workers, 95% CI 39.4-41.9). The prescription of proton pump inhibitors increased with age. Gastrointestinal protection was lacking in some participants who were being treated with drugs associated with a high risk of gastrointestinal bleeding. Heavy NSAID users (defined as those above the 95th percentile of consumption), accounted for 26% of total DDDs, and consumed a greater proportion of coxibs than non-heavy users. Conclusions: The rate of NSAID consumption in the cohort was high. To reduce the risk of gastrointestinal complications, monitoring and adequate gastroprotection are essential in patients who are prescribed NSAIDs for long periods of time or who are treated concomitantly with drugs that increase the risk of gastrointestinal bleeding.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] A REVIEW OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    ROSENBLOOM, D
    CRAVEN, MA
    CANADIAN FAMILY PHYSICIAN, 1983, 29 (NOV) : 2121 - 2124
  • [32] Safety of non-steroidal anti-inflammatory drugs
    Weintraub, William S.
    EUROPEAN HEART JOURNAL, 2017, 38 (44) : 3293 - 3295
  • [33] Pharmacogenetics of non-steroidal anti-inflammatory drugs
    Rollason, V.
    Samer, C.
    Desmeules, J. A.
    DOULEUR ET ANALGESIE, 2013, 26 (04): : 195 - 202
  • [34] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND CYTOTOXICS
    POWLES, TJ
    MILLAR, JL
    CANCER TREATMENT REVIEWS, 1979, 6 : 63 - 67
  • [35] INTERACTIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    TONKIN, AL
    WING, LMH
    BAILLIERES CLINICAL RHEUMATOLOGY, 1988, 2 (02): : 455 - 483
  • [36] Non-steroidal anti-inflammatory drugs (NSAIDs)
    Day, Richard O.
    Graham, Garry G.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [37] Intolerance to non-steroidal anti-inflammatory drugs
    Lakhoua, Ghozlane
    Zaiem, Ahmed
    Sahnoun, Rym
    El Aidli, Sihem
    Daghfous, Ryadh
    Kastalli, Sarrah
    THERAPIE, 2016, 71 (05): : 525 - 528
  • [38] Non-steroidal anti-inflammatory drugs for sciatica
    Rasmussen-Barr, Eva
    Held, Ulrike
    Grooten, Wilhelmus J. A.
    Roelofs, Pepijn D. D. M.
    Koes, Bart W.
    van Tulder, Maurits W.
    Wertli, Maria M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (10):
  • [39] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS HEPATITIS
    FURET, Y
    METMAN, EH
    BRETEAU, M
    BERTRAND, J
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1987, 23 (07): : 367 - 374
  • [40] Non-steroidal anti-inflammatory drugs in athletes
    Lippi, G.
    Franchini, M.
    Guidi, G. C.
    BRITISH JOURNAL OF SPORTS MEDICINE, 2006, 40 (08) : 661 - 662